Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on June 6, 2025
Collaboration entre OBI Pharma et TegMine Therapeutics autour des ADC, reposant sur les technologies habilitantes GlycOBI® et TegMiner™
GlobeNewswire
·
June 6, 2025
TAIPEI, Taïwan, 06 juin 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (OBI), une société internationale d’oncologie au stade clinique, spécialisée dans le développement de nouvelles thérapies contre le cancer, telles que les conjugués anticorps-médicaments ( …
Medifirm Intelledge Global Launches AI-Powered Platform and Strategic Consulting Services for Pharma and Life Sciences
EIN Presswire
·
June 6, 2025
Company combines advanced analytics, verified drug databases, and consulting expertise to support life sciences firms in navigating competitive global markets. GURUGRAM, HARYANA, INDIA, June 6, 2025 /EINPresswire.com/ -- Medifirm Intelledge Global Pvt. …
India Taxi Online Launches Cancer Treatment Navigator in Mumbai to Provide Safe, Transport for Cancer Patients
EIN Presswire
·
June 6, 2025
India Taxi Online introduces Cancer Treatment Navigator in Mumbai, offering safe, affordable, and reliable transport for cancer patients and their caregivers. MUMBAI, MAHARASHTRA , INDIA, June 6, 2025 /EINPresswire.com/ -- India Taxi Online, a leading …
First Ascent Biomedical and Fight Colorectal Cancer Announce Groundbreaking Study to Advance Precision Oncology for Colorectal Cancer Patients
GlobeNewswire
·
June 6, 2025
Springfield, Mo., June 06, 2025 (GLOBE NEWSWIRE) -- First Ascent Biomedical (FA), an innovative biotech company specializing in transforming cancer treatment through functional precision medicine, is proud to announce a new collaboration with national …
Zideas AI Lab and FindYourZen Launch Strategic Alliance to Tackle Gen Z Mental Health Crisis with AI-Driven Solution
EIN Presswire
·
June 6, 2025
A strategic alliance between Zideas AI Lab and FindYourZen to address the escalating mental health challenges for Gen Z. NEW YORK, NY, UNITED STATES, June 6, 2025 /EINPresswire.com/ -- We are thrilled to announce the first official collaboration from …
American Botanical Council Acquires Full Rights to Steven Foster Photo Library
GlobeNewswire
·
June 6, 2025
Austin, Texas, June 06, 2025 (GLOBE NEWSWIRE) -- The nonprofit American Botanical Council (ABC) announces that it has obtained ownership rights to the entire collection of medicinal and aromatic plant photographs taken by the late botanist, author, and …
Amazing Sesame Introduces Black Sesame Sauce: A Bold New Staple for the Modern Table
EIN Presswire
·
June 6, 2025
Amazing Sesame introduces a rich, velvety sauce that transforms everyday dishes into gourmet experiences. LAOS, LAOS, June 6, 2025 /EINPresswire.com/ -- Amazing Sesame, the brand known for reimagining Asian culinary staples through a modern lens, …
Aventis Graduate School’s Counselling & Psychotherapy Masters Earns Singapore Association for Counselling Accreditation
EIN Presswire
·
June 6, 2025
Aventis Singapore's MA in Counselling …
Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032
GlobeNewswire
·
June 6, 2025
FLORHAM PARK, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT) today announced that the U.S. Food and Drug Administration (FDA) has approved Phathom’s Citizen Petition filed on December 11, 2024 and communicated the …
Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
GlobeNewswire
·
June 6, 2025
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 6 June 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in …
Press release: Transparency Notification from Shareholders
GlobeNewswire
·
June 6, 2025
Transparency Notification from Shareholders Ghent, Belgium – 6 June 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and …
Isha Foundation’s Meditation App Surpasses ChatGPT’s Launch Pace, Signals Global Demand for Digital Stillness
GlobeNewswire
·
June 6, 2025
Los Angeles, CA, June 06, 2025 (GLOBE NEWSWIRE) -- As artificial intelligence dominates headlines, one of the fastest-growing wellness apps is turning heads for a different reason: silence. The Isha Foundation recently launched Miracle of Mind, a free …
Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
·
June 6, 2025
TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into definitive agreements for the purchase and sale of 434, …
European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy
GlobeNewswire
·
June 6, 2025
Now approved in the EU, Duvyzat offers an important treatment option for delaying Duchenne muscular dystrophy (DMD) disease progression Duvyzat is an orally administered treatment for DMD in patients 6 years and older who are able to walk The approval is …
BioNTX to Join Strategic Partners at BIO International Convention, Showcasing North Texas as a Converging Life Sciences Powerhouse
GlobeNewswire
·
June 6, 2025
DALLAS, June 06, 2025 (GLOBE NEWSWIRE) -- BioNTX, the leading voice of the bioscience and healthcare innovation ecosystem in North Texas, is proud to announce its attendance at the upcoming 2025 BIO International Convention, the world’s largest biotech …
Sionna Therapeutics Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model
GlobeNewswire
·
June 6, 2025
Data featured in oral presentation and poster session at 48th European Cystic Fibrosis Conference WALTHAM, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to …
Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders
GlobeNewswire
·
June 6, 2025
TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced the results of its Annual Meeting of …
President of the Association of American Physicians and Surgeons (AAPS) Writes, ‘Let’s Make America Healthy Again’
GlobeNewswire
·
June 6, 2025
TUCSON, Ariz., June 06, 2025 (GLOBE NEWSWIRE) -- The Make America Healthy Again (MAHA) project is a monumental task, writes Erika L. LeBaron, DO., M.S.N., in the summer issue of the Journal of American Physicians and Surgeons. Dr. LeBaron, current …
Immix Biopharma Attends FDA CEO Forum in Washington DC
GlobeNewswire
·
June 6, 2025
– Selected to Attend In-Person Event on June 5 led by FDA Commissioner Marty A. Makary, M.D., M.P.H. – LOS ANGELES, CA, June 06, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage …
Soligenix Highlights Dr. Ellen Kim’s Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials
GlobeNewswire
·
June 6, 2025
PRINCETON, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet …